# Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/health-care-resource-use-for-modern-first-line-treatments-in-metastatic-renal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Neil J. Shah,Reshma Shinde,Kristin J. Moore,Amy Sainski‐Nguyen,Lisa Le,Feng Cao,Rui Song,Puneet K. Singhal,Robert J. Motzer |
| Citations | 7 |
| DOI | 10.1001/jamanetworkopen.2024.22674 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1001/jamanetworkopen.2024.22674 |
| OpenAlex ID | https://openalex.org/W4400978073 |
| PMID | 39052293 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Amy Sainski‐Nguyen](https://scholariq.org/researchers/amy-sainski-nguyen/)

## Paper journal

- [JAMA Network Open](https://scholariq.org/journals/jama-network-open/)

## Paper primary topic

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Paper topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.